Cite
HARVARD Citation
Mason, C. et al. (n.d.). 1052. Characterisation of the DNA binding properties of ridinilazole, a selective antibiotic currently in phase III trials for the treatment of Clostridioides difficile. Open forum infectious diseases. p. S617. [Online].